Many regions in the Northern Hemisphere experienced a slightly earlier start to their flu season, driven in some part by a novel variant of influenza A(H3N2). As our flu season also kicks off slightly earlier than usual, Elri Voigt reports on detection of this variant in South Africa and what we might expect from this year’s flu season.
Childhood immunisation programmes have saved many millions of lives and prevented much suffering. Yet, immunisation programmes have lost momentum over the last decade or so. In this Spotlight special briefing, Elri Voigt unpacks the available data and considers how immunisation efforts might be revitalised.
COVID-19 has largely dropped out of the headlines, but the virus that causes it is still circulating. Biénne Huisman asks what we should know about a new variant of SARS-CoV-2, the state of the COVID-19 pandemic in 2025, and the lack of access to updated vaccines in South Africa.
Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Catherine Tomlinson unpacks why these new antibiotics are important and what needs to happen before they can be used in South Africa.
The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used in some other countries, but has not yet been registered in South Africa, though it can be obtained by those with money who are willing to jump through some hoops. Catherine Tomlinson reports.
The African Centre for Disease Control and World Health Organization have raised the alarm following a drastic uptick in mpox cases. This surge is being driven by a new strain of the virus. Elri Voigt reports about what we know so far and potential implications for South Africa.
Evidence suggests that even the tiniest amount of lead is detrimental to our health – and that’s bad news for people in South Africa, who are exposed to large amounts of the metal. Jesse Copelyn explores why lead does so much damage to the brain and heart, and why scientists keep finding it’s worse than we’d previously thought.
As a child growing up in Uganda, Maureen Etuket used a screwdriver to dismantle electronic appliances and toy trucks. Now, a PhD candidate in Industrial Engineering, this curiosity has been driving her quest to find solutions to public healthcare challenges. Last month, she won the Mandela Rhodes Foundation’s award for social impact in Africa for a device that can help save the lives of women who suffer excessive bleeding after child birth. Bienne Huisman chatted with her about the device, medical innovation in Africa, and finding one’s purpose in this challenging field.
For the past 128 years, a hospital tucked away on what was once a rural farm in Johannesburg East has been fighting to turn the tables on a disease that has plagued humankind for millennia. Ufrieda Ho has the latest in Spotlight’s special series of ‘Hospital Histories’.
During the height of the COVID-19 pandemic, many committees and organisations were working around the clock to prepare the country for the rollout of COVID-19 vaccines. Professor Hannelie Meyer, a pharmacist-turned-academic and later vaccine advocate, served on several of these committees. Elri Voigt spoke to Meyer about the pandemic, the mottos that guide her, and being an unapologetic workaholic.
Tracing the close contacts of people ill with tuberculosis (TB) and offering them TB preventive therapy is part of South Africa’s strategy to fight TB. A recent analysis found that such an approach of tracing household contacts and providing them with TB preventive treatment is cost-effective and would – by 2025 – cut deaths by 35% among household contacts of all ages and people living with HIV. In light of these new findings, Tiyese Jeranji assesses the state of contact tracing in South Africa’s public healthcare system.
A landmark global observational study found that many neonates get life-threatening bloodstream infections, or sepsis, and are dying because the antibiotics used to treat them are not effective. Sepsis affects up to 3 million babies a year globally and the study authors estimate that 214 000 newborns die every year from sepsis that has become antibiotic resistant – mainly in low- to middle-income countries. Adele Baleta reports.
